Cadre price target raised to $44 from $35 at Roth Capital

Roth Capital raised the firm’s price target on Cadre (CDRE) to $44 from $35 and keeps a Buy rating on the shares following the investor day. The firm believes investors “will welcome” the details Cadre provided on its nuclear safety platform, as the business has been viewed as a bit of a “black box” by generalists since the segment was introduced. Roth believes the company’s core business continues to perform well.